Rostafuroxin protects from podocyte injury and proteinuria induced by adducin genetic variants and ouabain.

Abstract excerpt

Glomerulopathies are important causes of morbidity and mortality. Selective therapies that address the underlying mechanisms are still lacking. Recently, two mechanisms, mutant β-adducin and ouabain, have been found to be involved in glomerular podocytopathies and proteinuria through nephrin downregulation. The main purpose of the present study was to investigate whether rostafuroxin, a novel antihypertensive...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Antihypertensive Agents
• Share to Calmodulin-Binding Proteins